AnaptysBio, Inc.
(NASDAQ : ANAB)

( )
ANAB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. 0.00%582.522.7%$671.55m
GILDGilead Sciences, Inc. -0.68%59.601.0%$574.83m
AMGNAmgen, Inc. -1.64%219.791.3%$569.60m
VRTXVertex Pharmaceuticals, Inc. 0.00%212.191.9%$533.31m
MRNAModerna, Inc. -0.74%70.150.0%$447.68m
ILMNIllumina, Inc. 0.00%321.743.5%$422.57m
EXASEXACT Sciences Corp. 0.00%131.1220.7%$294.14m
ALXNAlexion Pharmaceuticals, Inc. 0.00%120.002.0%$268.90m
NVAXNovavax, Inc. -2.12%87.6996.5%$268.13m
BIIBBiogen, Inc. -1.68%251.001.7%$259.69m
BNTXBioNTech SE -4.23%80.400.0%$202.55m
SRNESorrento Therapeutics, Inc. 1.17%7.801.4%$153.07m
SGENSeagen Inc. 0.00%196.926.0%$150.43m
CRSPCRISPR Therapeutics AG 0.00%98.120.6%$126.32m
TXG10X Genomics, Inc. 0.00%142.930.0%$104.03m

Company Profile

AnaptysBio, Inc. is a clinical stage biotechnology company, which engages in developing antibody product candidates focused on unmet medical needs in inflammation. Its products pipeline include ANB020, ANB019, and checkpoint receptor agonist antibodies. The company was founded by Andrew B. Cubitt, William J. Boyle and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.